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MaA previously fit and well 30-year-old man presented with palpitations, fever, and pleuritic chest pain.
Multimodality imaging and histopathology confirmed the diagnosis of primary cardiac angiosarcoma. We present
the details of the presentation, diagnostic process using multimodality imaging, and clinical management.
(Level of Difficulty: Beginner.) (J Am Coll Cardiol Case Rep 2021;3:944–9) © 2021 The Authors. Published by Elsevier on
behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).HISTORY OF PRESENTATION
A previously fit and well 30-year-old man presented
to the emergency department with palpitations, fe-
ver, and pleuritic chest pain. He also described an
acute reduction in his exercise tolerance.EARNING OBJECTIVES
To understand the 2 distinct clinical pre-
sentations of cardiac angiosarcoma and how
these relate to the underlying morphological
features.
To review the diagnostic features of angio-
sarcoma on cardiovascular magnetic reso-
nance imaging.
To revisit therapeutic options and the
importance of multidisciplinary care in this
rare condition.
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rate of 110 beats/min and low-grade pyrexia of 37.8C
were detected. Oxygen saturations were 97% on room
air, and blood pressure was normal. There were no
signs of congestive cardiac failure or audible mur-
murs on pre-cordial auscultation.
MEDICAL HISTORY
The medical history was unremarkable.
DIFFERENTIAL DIAGNOSIS
Given the history of pleuritic chest pain and fever and
the timing of this presentation during the COVID-19
pandemic, coronavirus infection was the primary
differential diagnosis. Venous pulmonary embolism
and bacterial or other viral causes of pneumonia were
also considered. Blood tests including D-dimer, elec-
trocardiogram, and plain film chest x-ray film were
ordered.https://doi.org/10.1016/j.jaccas.2021.03.009
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AB BR E V I A T I O N S
AND ACRONYM S
CMR = cardiovascular magnetic
resonance imaging
RA = right atrial
RCA = right coronary artery
RV = right ventricle
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Full blood count showed a normocytic anemia.
Although C-reactive protein (158 mg/l) and D-dimer
(840 ng/ml) levels were raised, troponin I level
(27.3 ng/l) was not raised. Liver function test results
were normal.
COVID-19 swabs were negative.
Electrocardiogram showed sinus tachycardia at 114
beats/min (Figure 1). Chest x-ray film findings were
unremarkable.
Given the presentation of pleuritic chest pain with
sinus tachycardia and elevated D-dimer, computed
tomography pulmonary angiogram was ordered. This
excluded pulmonary embolism but demonstrated a
large soft tissue mass in the anterior mediastinum
(Figure 2).
Transthoracic echocardiogram confirmed the
presence of a large hypoechoic right atrial (RA) mass.
The patient was admitted to the ward for further
assessment.
Cardiac magnetic resonance (CMR) confirmed the
presence of an RA mass measuring 12  8 cm, filling
>90% of the chamber lumen (Video 1). The mass was
invading the RA lateral wall, atrioventricular groove,
and anterior tricuspid valve cusp and compressing the
inferior vena cava. Global pericardial effusion with a
maximal diameter measuring 2 cm around the right
ventricle (RV) free wall was detected. The mass
showed heterogeneous signal intensity on T1- and T2-
weighted imaging (Figures 3 and 4) and on early
and late gadolinium enhancement imaging (Figures 5
and 6). First-pass perfusion imaging with a standard
rest perfusion sequence demonstrated regions of het-
erogeneous enhancement with visually higherFIGURE 1 Electrocardiogram Showing Sinus Tachycardiaperfusion at themargins than at the core of the
lesion, likely due to regional variations in
vascularity and regions of necrosis at the core
of the mass (Video 2). Left ventricle systolic
functionwas globallymildly impaired, with an
ejection fraction of 50%. The base of the RV
free wall was invaded by the mass; mid and
apical RV function was preserved. A pre-
liminary diagnosis of cardiac angiosarcoma
was suggested based on CMR appearances.
No functional tricuspid valve stenosis was detected
on transesophageal echocardiography (Figure 7).
The RA mass demonstrated moderate uptake on
fluorodeoxyglucose–positron emission tomography
scan. Lymph node involvement was seen with low-
grade hyperenhancement of the right internal
mammary nodes. There was focal fluorodeox-
yglucose uptake in the right iliac crest and left
anterior iliac spine compatible with bony metasta-
ses (Figures 8 and 9).
Transjugular core biopsy was performed for histo-
pathologic analysis. This showed a spindle cell tumor,
staining strongly with CD34 and ERG (erythroblast
transformation-specific related gene), confirming the
radiological suspicion of angiosarcoma.
Coronary angiography was performed in prepara-
tion for debulking surgery. This showed a highly
vascular tumor with supply from the right coronary
artery (RCA) and proximal circumflex artery. There
was also a mass effect compressing the RCA (Videos 3
and 4).
MANAGEMENT
Because of the presence of widespread metastatic
disease and the extent of regional spread and size of
FIGURE 2 Computed Tomography Pulmonary Angiogram Showing an Anterior Mediastinal Mass
FIGURE 3 T1-Weighted Cardiac Magnetic Resonance Image Showing the Right Atrial Mass
FIGURE 4 T2-Weighted Cardiac Magnetic Resonance Image Showing the Right Atrial Mass
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FIGURE 5 Early Gadolinium Enhanced Cardiac Magnetic Resonance Image of the Right Atrial Mass
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be possible by the multidisciplinary team.
The patient underwent successful debulking sur-
gery with reconstruction of the RA wall and grafting
of the RCA. Post-operative transesophageal echocar-
diography showed preserved left ventricle systolic
function with mildly dilated and impaired RV systolic
function (Videos 5, 6, 7, 8, and 9).
Following surgery, the patient underwent pallia-
tive chemotherapy with doxorubicin and palliative
radiotherapy at the sites of bony metastases.FIGURE 6 Late Gadolinium Enhanced Cardiac Magnetic Resonance ImDISCUSSION
Angiosarcoma is the most common primary cardiac
malignancy in adulthood, comprising 9% of all pri-
mary cardiac tumors (1). Angiosarcomas typically
occur in the RA (90%) and more commonly affect men
(2). Presentation is typically between the third and
fifth decades of life (3) and carries a poor prognosis
because of the rapid growth of the tumor and
frequent presence of metastases at the time of diag-
nosis (2). Histologically, angiosarcomas show rapidlyage of the Right Atrial Mass
FIGURE 7 Transesophageal Echocardiography Showing no Functional Tricuspid Valve
Stenosis
FIGURE 8 Fluorodeoxyglucose–Positron Emission Tomography Showing Moderate
Uptake in the Right Atrial Mass
FIGURE 9 Fluorodeoxyglucose–Positron Emission Tomography Showing Uptake in the
Anterior Iliac Spine Compatible With Bony Metastases
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the vasculature. Tumors have well-differentiated
vascular channels combined with poorly differenti-
ated areas of epithelioid and spindle cells (2).
There are typically 2 distinct clinical presentations,
reflecting the 2 common morphological variants of
the tumor (1). The focal well-defined form, as seen in
our case, with a mass protruding into the RA presents
with symptoms related to severe intracavity
obstruction. These patients most commonly present
with dyspnea and chest pain. The diffuse form of the
disease rapidly invades the RV and the pericardium,
resulting in heart failure or cardiac tamponade due to
the tumor’s permeating and destructive nature (1).
The CMR features of angiosarcoma are character-
ized by a heterogenous RA mass with or without
pericardial involvement. Heterogeneity on T1- and T2-
weighted images and LGE reflects areas of tumor tis-
sue, necrosis, and hemorrhage (1). Arterial phase
enhancement on first-pass perfusion imaging reflects
the vascularity of the tumor. Our case reveals that
large tumors may have heterogenous perfusion with
higher vascularity only at the margins, likely due to
the presence of necrosis at the core of the lesion.
Although the presenting symptoms of breathless-
ness and palpitations are reported in similar fre-
quencies for both benign and malignant RA masses,
the size of the mass (>5 cm), invasion of the RV base,
variable tissue intensity on T1- and T2-weighted CMR
images, high perfusion uptake, and accompanying
moderate pericardial effusion indicated a malignant
tumor. Accordingly, metastatic malignancies and
lymphomas were considered as the most likely dif-
ferential diagnosis. Lymphomas, the primary differ-
ential, are typically homogenous and isointense on
T1- and T2-weighted images with minimal contrast
uptake on LGE (1).
The prognosis of angiosarcoma is poor, with a me-
dian survival of 14 months, reducing to 6 months in
metastatic disease (3). Palliative treatment with sur-
gical debulking and chemoradiotherapy may offer
some prognostic benefit (4). Anthracyclines, ifosfa-
mide, and taxanes are the most commonly used agents
(5). Immunotherapy with recombinant interleukin 2
has been used with some prognostic benefit (6).
In our case, the multidisciplinary team decision
was for surgical debulking to provide the best option
for palliative care, given the degree of RA cavity
obstruction, and to allow time for chemotherapy
administration.
Because of the rare incidence of cardiac angio-
sarcomas, there is a dearth of evidenced-based
guidelines, and currently, no standardized treat-
ment algorithm for cardiac angiosarcoma exists (3).
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Following surgery and palliative chemoradiotherapy,
repeat imaging showed significant metastatic disease
progression within the lungs and pelvis. In addition
to doxorubicin and single-slice radiotherapy, hospice
services were engaged. The patient died 4 months
following the initial diagnosis.
CONCLUSIONS
This case demonstrates the typical presentation of
primary cardiac angiosarcoma and its associated fea-
tures on multimodality imaging. Multidisciplinary
care of this relatively rare tumor is important, whichreflects the lack of consensus guidelines on
management.
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